Next-generation biomonitoring of the early-life chemical exposome in neonatal and infant development

Nature Communications
2022.0

Abstract

Exposure to synthetic and natural chemicals is a major environmental risk factor in the etiology of many chronic diseases. Investigating complex co-exposures is necessary for a holistic assessment in exposome-wide association studies. In this work, a sensitive liquid chromatography-tandem mass spectrometry approach was developed and validated. The assay enables the analysis of more than 80 highly-diverse xenobiotics in urine, serum/plasma, and breast milk; with detection limits generally in the pg-ng mL(-1) range. In plasma of extremely-premature infants, 27 xenobiotics are identified; including contamination with plasticizers, perfluorinated alkylated substances and parabens. In breast milk samples collected longitudinally over the first 211 days post-partum, 29 analytes are detected, including pyrrolizidine- and tropane alkaloids which have not been identified in this matrix before. A preliminary estimation of daily toxicant intake via breast milk is conducted. In conclusion, we observe significant early-life co-exposure to multiple toxicants, and demonstrate the method's applicability for large-scale exposomics-type cohort studies. CI - (c) 2022. The Author(s).

Knowledge Graph

Similar Paper

Next-generation biomonitoring of the early-life chemical exposome in neonatal and infant development
Nature Communications 2022.0
Development and validation of a liquid chromatography–tandem mass spectrometry assay for the analysis of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in plasma, urine, bile, intestinal contents, faeces and eight selected tissues from mice
Journal of Chromatography B 2010.0
Simultaneous detection of 22 toxic plant alkaloids (aconitum alkaloids, solanaceous tropane alkaloids, sophora alkaloids, strychnos alkaloids and colchicine) in human urine and herbal samples using liquid chromatography–tandem mass spectrometry
Journal of Chromatography B 2013.0
Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2‐HPMA), acrolein (3‐HPMA), acrylamide (AAMA) and <i>N,N</i>‐dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry
Rapid Communications in Mass Spectrometry 2008.0
Analysis of Mitragynine and Speciociliatine in Umbilical Cord by LC–MS-MS for Detecting Prenatal Exposure to Kratom
Journal of Analytical Toxicology 2023.0
Gelsemium Intoxication in a child detected using targeted and untargeted urinary toxicological screening
Toxicologie Analytique et Clinique 2023.0
Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM01183 (lurbinectedin), a novel antineoplastic agent, in mouse, rat, dog, Cynomolgus monkey and mini-pig plasma
Journal of Pharmaceutical and Biomedical Analysis 2016.0
Analysis of polyamines as carbamoyl derivatives in urine and serum by liquid chromatography–tandem mass spectrometry
Biomedical Chromatography 2008.0
Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers—A powerful strategy for breast cancer diagnosis
Talanta 2012.0
Microanalysis of β-Lactam Antibiotics and Vancomycin in Plasma for Pharmacokinetic Studies in Neonates
Antimicrobial Agents and Chemotherapy 2009.0